Last quarter (Q1 2023), Aligos Therapeutics's total revenue was $140.00K, a decrease of -94.55% from the same quarter last year. In Q1, Aligos Therapeutics's net income was $-22.95M. See Aligos Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 7.94M	-	$ 4.36M	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 140.00K	-	-	-	-	-
Operating Expense	$ 98.15M	$ 111.49M	$ 132.68M	$ 97.83M	$ 54.04M	$ 13.66M
Operating Income	$ -90.21M	$ -109.85M	$ -128.32M	$ -97.83M	$ -54.04M	$ -13.66M
Net Non Operating Interest Income Expense	$ 691.00K	$ 13.00K	$ 132.00K	$ -10.55M	$ 1.86M	$ 163.00K
Other Income Expense	$ -5.94M	$ -13.85M	-	$ -10.55M	$ 302.00K	$ -435.00K
Pretax Income	$ -83.35M	$ -95.94M	$ -128.19M	$ -108.38M	$ -52.18M	$ -13.93M
Tax Provision	$ 92.00K	$ 106.00K	$ 143.00K	$ 161.00K	$ 85.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -83.44M	$ -96.10M	$ -128.33M	$ -108.54M	$ -52.26M	$ -13.93M
Basic EPS	$ -1.00	-	$ -3.22	$ -10.87	$ -2.47	$ -0.66
Diluted EPS	$ -1.94	$ -2.25	$ -3.22	$ -10.87	$ -2.47	$ -0.66
Basic Average Shares	$ 171.03M	$ 42.70M	$ 39.86M	$ 9.99M	$ 21.17M	$ 21.17M
Diluted Average Shares	$ 128.34M	$ 42.70M	$ 39.86M	$ 9.99M	$ 21.17M	$ 21.17M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 98.15M	$ 111.49M	$ 132.68M	$ 97.83M	$ 54.04M	$ 13.66M
Net Income From Continuing And Discontinued Operation	$ -83.44M	$ -96.05M	$ -128.33M	$ -108.54M	$ -52.26M	$ -13.93M
Normalized Income	$ -38.55M	-	$ -128.33M	$ -108.54M	$ -52.26M	$ -13.93M
Interest Expense	-	-	-	$ 10.55M	-	-
EBIT	$ -84.16M	$ -95.95M	$ -128.32M	$ -97.83M	$ -54.04M	$ -13.66M
EBITDA	$ -80.94M	$ -92.44M	$ -124.54M	$ -94.51M	$ -51.74M	$ -12.37M

Currency in USD

Aligos Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing